Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.87ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.87NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.58 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.58 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.58 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.58 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBGORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBGENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBGNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.98 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.98 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.98 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.98 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used